Top 4 Small-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

by Monica Gerson, Benzinga Staff Writer

October 22, 2013 4:29 AM | 1 min read | Make a Comment

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio. Idenix Pharmaceuticals

IDIX

has a PEG ratio of 0.11. Idenix's trailing-twelve-month revenue is $33.54 million. Exelixis

EXEL

has a PEG ratio of 0.17. Exelixis had $351.97 million in total cash for the latest quarter. InterMune

ITMN

has a PEG ratio of 0.30. InterMune is expected to post revenue of $20.91 million for the December quarter. Lexicon Pharmaceuticals

LXRX

has a PEG ratio 0.62. Lexicon's trailing-twelve-month revenue is $1.16 million.

Posted In: Trading Ideas Biotechnology Biotechnology Industry Health Care PEG ratio Small caps small-cap

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.